⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LBRX News
LB Pharmaceuticals Inc Common Stock
Form 8-K
sec.gov
LBRX
Form 8-K
sec.gov
LBRX
Apnimed Appoints Experienced Pharmaceutical Executive Kevin R. Lind as Chief Executive Officer to Implement Next Phase of Growth Strategy
prnewswire.com
LBRX
VTVT
VEEV
LB Pharmaceuticals to Participate in Upcoming June Investor Events
globenewswire.com
LBRX
American Urological Association Announces the Early-Stage Innovation Nexus Awardee Sponsored by Laborie
globenewswire.com
LBRX
Form 8-K
sec.gov
LBRX
LB Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
LBRX
LayerBio Announces FDA Acceptance of Investigational New Drug (IND) Application for OcuRing-K, a Sustained-Release Ketorolac Implant for Cataract Surgery Patients
accessnewswire.com
LBRX
LB Pharmaceuticals Announces Publication in JAMA Psychiatry of Results from Phase 2 NOVA-1 Trial of LB-102 in Schizophrenia
globenewswire.com
LBRX
LB Pharmaceuticals Announces Presentation at 25th Annual Needham Virtual Healthcare Conference
globenewswire.com
LBRX